Although there is a clear connection between BCR-ABL1 fusion and cell cycle regulation, only very limited data is available for the evaluation of CDKIs in chronic myeloid leukemia (CML). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.